RNC Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $55.5M | Buy |
451,991
+6,947
| +2% | +$844K | 2.53% | 15 |
|
|
2025
Q3 | $49.4M | Sell |
445,044
-10,845
| -2% | -$1.23M | 2.27% | 18 |
|
|
2025
Q2 | $50.5M | Sell |
455,889
-696
| -0.2% | -$74.1K | 2.45% | 15 |
|
|
2025
Q1 | $51.2M | Sell |
456,585
-2,085
| -0.5% | -$215K | 2.61% | 14 |
|
|
2024
Q4 | $42.4M | Sell |
458,670
-190,748
| -29% | -$17.2M | 2.26% | 20 |
|
|
2024
Q3 | $44.6M | Hold |
649,418
| – | – | 2.47% | 17 |
|
|
2024
Q2 | $44.6M | Buy |
649,418
+22,697
| +4% | +$1.51M | 2.47% | 17 |
|
|
2024
Q1 | $45.9M | Sell |
626,721
-51,714
| -8% | -$3.98M | 2.61% | 14 |
|
|
2023
Q4 | $55M | Sell |
678,435
-3,391
| -0.5% | -$264K | 3.29% | 6 |
|
|
2023
Q3 | $51.1M | Sell |
681,826
-26,668
| -4% | -$2.05M | 3.17% | 9 |
|
|
2023
Q2 | $54.6M | Buy |
708,494
+1,515
| +0.2% | +$121K | 3.02% | 7 |
|
|
2023
Q1 | $58.7M | Buy |
706,979
+2,038
| +0.3% | +$169K | 3.31% | 5 |
|
|
2022
Q4 | $60.5M | Buy |
704,941
+18,841
| +3% | +$1.49M | 3.39% | 6 |
|
|
2022
Q3 | $42.3M | Buy |
686,100
+145,858
| +27% | +$9.2M | 2.66% | 12 |
|
|
2022
Q2 | $33.4M | Buy |
540,242
+12,878
| +2% | +$797K | 1.9% | 23 |
|
|
2022
Q1 | $31.4M | Sell |
527,364
-2,255
| -0.4% | -$144K | 1.59% | 29 |
|
|
2021
Q4 | $38.5M | Buy |
529,619
+83,870
| +19% | +$5.78M | 1.9% | 22 |
|
|
2021
Q3 | $31.1M | Buy |
445,749
+2,984
| +0.7% | +$210K | 1.66% | 30 |
|
|
2021
Q2 | $30.5M | Buy |
442,765
+156,449
| +55% | +$10.4M | 1.61% | 32 |
|
|
2021
Q1 | $18.5M | Buy |
286,316
+74,710
| +35% | +$4.82M | 1.05% | 35 |
|
|
2020
Q4 | $12.3M | Sell |
211,606
-103,618
| -33% | -$6.25M | 0.77% | 39 |
|
|
2020
Q3 | $19.9M | Sell |
315,224
-14,419
| -4% | -$1,000K | 1.41% | 35 |
|
|
2020
Q2 | $25.4M | Buy |
329,643
+8,212
| +3% | +$629K | 1.83% | 27 |
|
|
2020
Q1 | $24M | Buy |
321,431
+298,169
| +1,282% | +$20.6M | 2.05% | 24 |
|
|
2019
Q4 | $1.51M | Buy |
23,262
+15,875
| +215% | +$1.03M | 0.1% | 85 |
|
|
2019
Q3 | $468K | Buy |
7,387
+60
| +0.8% | +$3.92K | 0.03% | 103 |
|
|
2019
Q2 | $495K | Sell |
7,327
-725
| -9% | -$47.7K | 0.03% | 101 |
|
|
2019
Q1 | $523K | Sell |
8,052
-222
| -3% | -$14.8K | 0.04% | 95 |
|
|
2018
Q4 | $518K | Sell |
8,274
-441
| -5% | -$30.8K | 0.04% | 99 |
|
|
2018
Q3 | $673K | Sell |
8,715
-2,090
| -19% | -$158K | 0.04% | 92 |
|
|
2018
Q2 | $765K | Sell |
10,805
-100
| -0.9% | -$7.06K | 0.05% | 86 |
|
|
2018
Q1 | $822K | Sell |
10,905
-550
| -5% | -$43.7K | 0.06% | 84 |
|
|
2017
Q4 | $821K | Sell |
11,455
-16
| -0.1% | -$1.22K | 0.06% | 84 |
|
|
2017
Q3 | $929K | Sell |
11,471
-72,231
| -86% | -$5.52M | 0.07% | 75 |
|
|
2017
Q2 | $5.92M | Buy |
83,702
+1,185
| +1% | +$78.9K | 0.46% | 44 |
|
|
2017
Q1 | $5.61M | Buy |
82,517
+5,510
| +7% | +$387K | 0.45% | 47 |
|
|
2016
Q4 | $5.51M | Sell |
77,007
-10,957
| -12% | -$814K | 0.46% | 47 |
|
|
2016
Q3 | $6.96M | Buy |
87,964
+16,997
| +24% | +$1.38M | 0.62% | 39 |
|
|
2016
Q2 | $5.92M | Sell |
70,967
-279
| -0.4% | -$24.8K | 0.55% | 44 |
|
|
2016
Q1 | $6.54M | Sell |
71,246
-94
| -0.1% | -$8.48K | 0.65% | 41 |
|
|
2015
Q4 | $7.22M | Sell |
71,340
-2,571
| -3% | -$268K | 0.72% | 42 |
|
|
2015
Q3 | $7.26M | Buy |
73,911
+3,238
| +5% | +$360K | 0.7% | 36 |
|
|
2015
Q2 | $8.27M | Sell |
70,673
-308
| -0.4% | -$33.7K | 0.7% | 36 |
|
|
2015
Q1 | $6.96M | Sell |
70,981
-1,636
| -2% | -$166K | 0.58% | 38 |
|
|
2014
Q4 | $6.84M | Buy |
72,617
+109
| +0.2% | +$11.3K | 0.56% | 41 |
|
|
2014
Q3 | $7.72M | Sell |
72,508
-320
| -0.4% | -$31.3K | 0.62% | 42 |
|
|
2014
Q2 | $6.04M | Sell |
72,828
-474
| -0.6% | -$36.9K | 0.49% | 44 |
|
|
2014
Q1 | $5.19M | Buy |
73,302
+1,685
| +2% | +$132K | 0.45% | 43 |
|
|
2013
Q4 | $5.38M | Buy |
71,617
+672
| +0.9% | +$46.8K | 0.48% | 45 |
|
|
2013
Q3 | $4.46M | Sell |
70,945
-425
| -0.6% | -$25.4K | 0.45% | 46 |
|
|
2013
Q2 | $3.66M | Buy |
+71,370
| New | +$3.72M | 0.39% | 49 |
|
Other funds holding GILD
RNC Capital Management's GILD Position: Q4 2025 in Review
RNC Capital Management increased its Gilead Sciences (GILD) stake by 1.6% in Q4 2025, buying an estimated $844K and bringing the position to 451,991 shares worth $55.5M. The position accounts for 2.53% of the portfolio, ranked #15.
RNC Capital Management first reported a position in GILD in Q2 2013 and has held it in 51 quarters since. The position peaked at $60.5M in Q4 2022. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.
- RNC Capital Management held 451,991 shares of Gilead Sciences worth $55.5M as of Q4 2025.
- RNC Capital Management bought 6,947 Gilead Sciences shares in Q4 2025, an estimated $844K.
- Gilead Sciences made up 2.53% of RNC Capital Management's portfolio in Q4 2025, its #15 holding.
- RNC Capital Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 51 quarters since.
- RNC Capital Management's Gilead Sciences position peaked at $60.5M in Q4 2022.
- 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.
Based on RNC Capital Management's 13F filing for Q4 2025, filed 3 Feb 2026.